MedTrace Logo

Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study

NCT02076061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-08-24

No results posted yet for this study

Summary

This is a longitudinal observational study to identify and validate protein biomarkers for COPD (chronic obstructive pulmonary diseases) and cardiovascular disease in smokers and ex-smokers attending primary care. Special emphasize is to correlate biomarkers to different phases of COPD, to progression of the disease, and to treatment of the disease. Furthermore, linkage between COPD, cardiovascular disease, and lung cancer will be investigated by identifying protein biomarkers.

Conditions

Sponsors & Collaborators

  • Örestadskliniken

    collaborator OTHER

  • Lund University

    lead OTHER

Principal Investigators

  • Johan Malm · Clincal Chemistry, Lund University

  • György Marko-Varga · Clinical Protein Science & Imaging, Lund University

  • Mikael Truedsson · Örestadskliniken Malmö

  • Elisabet Wieslander · Division of Oncology and Pathology, Lund University

  • Thomas E Fehniger · Clinical Protein Science & Imaging, Lund University

  • Magnus Dahlbäck · Clinical Protein Science & Imaging, Lund University

  • Roger Appelqvist · Clinical Protein Science & Imaging, Lund University

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076061 on ClinicalTrials.gov